Krka

Krka is one of the world's leading generic pharmaceutical companies, headquartered in Novo mesto, Slovenia. The company specializes in the development, production, and sale of high-quality generic prescription pharmaceuticals, non-prescription products, and animal health products. Krka operates a vertically integrated business model, controlling the entire process from the development of active pharmaceutical ingredients (APIs) to the marketing and distribution of finished products. With a presence in over 70 countries, Krka is a dominant player in Central, Eastern, and South-Eastern Europe. The company is increasingly expanding its footprint in Western Europe and overseas markets, including China. Krka is known for its 'value-added generics' and combination medicines, particularly in the cardiovascular and central nervous system therapeutic areas.